Inhibitory effect of sanguinarine on PKC-CPI-17 pathway mediating by muscarinic receptors in dispersed intestinal smooth muscle cells

Research in Veterinary Science

Volumn 95, Issue 3, 2013, Pages 1125-1133

  Wang, Hui ^a   Yin, Guohua ^b   Yu, Chun hong ^a   Wang, Yueshang ^c   Sun, Zhi Liang ^a  

^a HUNAN AGRICULTURAL UNIVERSITY   (China)

^b Environmental Research Laboratory   (United States)

^c Shandong Huaxi Pharmaceutical CO LTD   (China)

Author keywords

Ca2+; Intestinal smooth muscle cells (ISMC); M receptors; PKC CPI 17 pathway; Sanguinarine (SA)

Indexed keywords

CALCIUM; CARBACHOL; MESSENGER RNA; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C ETA; SANGUINARINE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CPI 17 GENE; DOWN REGULATION; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; INTESTINE MUSCLE; M2 RECEPTOR GENE; M3 RECEPTOR GENE; MUSCLE FIBER CONTRACTION; NONHUMAN; PKC DELTA GENE; PKC EPSILON GENE; PKC ETA GENE; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

RATTUS;

CA(2+); INTESTINAL SMOOTH MUSCLE CELLS (ISMC); M RECEPTORS; PKC-CPI-17 PATHWAY; SANGUINARINE (SA);

ANIMALS; BENZOPHENANTHRIDINES; BLOTTING, WESTERN; CALCIUM; INTESTINES; ISOQUINOLINES; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHOSPHOPROTEIN PHOSPHATASES; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; RATS; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION;

EID: 84887994415     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2013.07.022     Document Type: Article

References (49)

1. Baraban J.M., Gould R.J., Peroutka S.J., Snyder S.H. Phorbol ester effects on neurotransmission: interaction with neurotransmitters and calcium in smooth muscle. Proceedings of the National Academy of Sciences of the United States of America 1985, 82:604-607.
2. Blackwood A.M., Bolton T.B. Mechanism of carbachol-evoked contractions of guinea-pig ileal smooth muscle close to freezing point. British Journal of Pharmacology 1993, 109:1029-1037.
3. Bolton T.B., Gordienko D.V., Pucovsky V., Parsons S., Povstyan O. Calcium release events in excitation-contraction coupling in smooth muscle. Novartis Foundation Symposium 2002, 246:154-168.
4. 2 muscarinic receptors in guinea-pig ileum opens cationic channels modulated by m3 muscarinic receptors. Life sciences 1997, 60:1121-1128.
5. 3H]candesartan to the human angiotensin at1 receptor. European Journal of Pharmacology 2003, 458:257-262.
6. Chang, S., Hypolite, J.A., Mohanan, S., Zderic, S.A., Wein A.J., S. Chacko, S., 2009. Alteration of the pkc-mediated signaling pathway for smooth muscle contraction in obstruction-induced hypertrophy of the urinary bladder. Laboratory investigation; a journal of technical methods and pathology 89, 823-832.
7. Eglen R.M., Hegde S.S., Watson N. Muscarinic receptor subtypes and smooth muscle function. Pharmacological reviews 1996, 48:531-565.
8. Ehlert F.J., Ostrom R.S., Sawyer G.W. Subtypes of the muscarinic receptor in smooth muscle. Life sciences 1997, 61:1729-1740.
9. 3 muscarinic receptors in gastrointestinal smooth muscle. Life sciences 1999, 64:387-394.
10. 2+ sensitization of the contractile apparatus in vascular smooth muscle. Journal of Pharmacological Sciences 2007, 104:109-115.
11. 2+-influx pathways in taenia caeci. British Journal of Pharmacology 1997, 122:985-992.
12. Holzer P., Lippe I.T. Protein kinase c may regulate the tonic component of intestinal smooth muscle contraction in response to substance p. Naunyn-Schmiedebergs Archives of Pharmacology 1989, 339:214-220.
13. Hu C.M., Cheng H.W., Cheng Y.W., Kan J.J. Mechanisms underlying the induction of vasorelaxation in rat thoracic aorta by sanguinarine. Japanese Journal of Pharmacology 2001, 85:47-53.
14. 2 in smooth muscle. Biochemical and biophysical research communications 2006, 343:1038-1044.
15. Hu W., Mahavadi S., Li F., Murthy K.S. Upregulation of RGS4 and downregulation of cpi-17 mediate inhibition of colonic muscle contraction by interleukin-1β. American journal of physiology. Cell physiology 2007, 293:C1991-2000.
16. Inoue R., Isenberg G. Acetylcholine activates nonselective cation channels in guinea pig ileum through a g protein. American Journal of Physiology 1990, 258:C1173-1178.
17. Jang S.I., Kim B.H., Lee W.Y., An S.J., Choi H.G., Jeon B.H., Chung H.T., Rho J.R., Kim Y.J., Chai K.Y. Stylopine from chelidonium majus inhibits lps-induced inflammatory mediators in raw 264.7 cells. Archives of Pharmacal Research 2004, 27:923-929.
18. Ji H., Wang L., Bi H., Sun L., Cai B., Wang Y., Zhao J., Du Z. Mechanisms of lumbrokinase in protection of cerebral ischemia. European Journal Pharmacology 2008, 590:281-289.
19. Karaki H., Weiss G.B. Calcium channels in smooth muscle. Gastroenterology 1984, 87:960-970.
20. Kitada N., Takara K., Minegaki T., Itoh C., Tsujimoto M., Sakaeda T., Yokoyama T. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines. Cancer chemotherapy and pharmacology 2008, 62:577-584.
21. Komori S., Bolton T.B. Calcium release induced by inositol 1,4,5-trisphosphate in single rabbit intestinal smooth muscle cells. The Journal of Physiology 1991, 433:495-517.
22. 2+ influx in single intestinal smooth muscle cells. British Journal of Pharmacology 1996, 119:245-252.
23. 3 muscarinic receptors couple, respectively, with activation of nonselective cationic channels and potassium channels in intestinal smooth muscle cells. Japanese Journal of Pharmacology 1998, 76:213-218.
24. Mahady G.B., Beecher C.W. Quercetin-induced benzophenanthridine alkaloid production in suspension cell cultures of sanguinaria canadensis. Planta Medica 1994, 60:553-557.
25. 2+ release in mouse duodenal myocytes. British Journal of Pharmacology 1997, 121:451-458.
26. Murthy K.S. Signaling for contraction and relaxation in smooth muscle of the gut. Annual Review Physiology 2006, 68:345-374.
27. 2+ mediated by distinct PKC isozymes. American Journal of Physiology - Gastrointestinal and Liver Physiology 2000, 279:G201-210.
28. Murthy K.S., Makhlouf G.M. Agonist-mediated activation of phosphatidylcholine-specific phospholipase C and D in intestinal smooth muscle. Molecular pharmacology 1995, 48:293-304.
29. Murthy K.S., Makhlouf G.M. Functional characterization of phosphoinositide-specific phospholipase C-beta 1 and -beta 3 in intestinal smooth muscle. American Journal of Physiology - Cell Physiology 1995, 269:C969-978.
30. 3 receptors to adenylyl cyclases v/vi in smooth muscle. The Journal of Biological Chemistry 1997, 272:21317-21324.
31. 2 receptors determines sustained myosin light chain (MLC) phosphorylation and smooth muscle contraction. Gastroenterology 2001, 120:A20.
32. Ohama T., Hori M., Sato K., Ozaki H., Karaki H. Chronic treatment with interleukin-1beta attenuates contractions by decreasing the activities of CPI-17 and MYPT-1 in intestinal smooth muscle. The Journal of biological chemistry 2003, 278:48794-48804.
33. 2+, and tension in intact smooth muscles. American Journal of Physiology 1991, 260:C917-925.
34. Prestwich S.A., Bolton T.B. G-protein involvement in muscarinic receptor-stimulation of inositol phosphates in longitudinal smooth muscle from the small intestine of the guinea-pig. British Journal of Pharmacology 1995, 114:119-126.
35. Sakai H., Yamamoto M., Chiba Y., Misawa M. Probable involvement of epsilon-isoform of protein kinase C in rat bronchial smooth muscle contraction induced by acetylcholine. Journal of Smooth Muscle Research 2008, 44:9-16.
36. Sanders K.M. Regulation of smooth muscle excitation and contraction. Neurogastroenterology and Motility 2008, 20:39-53.
37. Sasaguri T., Watson S.P. Protein kinase C regulates the tonic but not the phasic component of contraction in guinea-pig ileum. British Journal of Pharmacology 1989, 98:791-798.
38. Sato K., Ohkura S., Kitahara Y., Ohama T., Hori M., Sato M., Kobayashi S., Sasaki Y., Hayashi T., Nasu T., Ozaki H. Involvement of CPI-17 downregulation in the dysmotility of the colon from dextran sodium sulphate-induced experimental colitis in a mouse model. Neurogastroenterology and Motility 2007, 19:504-514.
39. Seithel A., Karlsson J., Hilgendorf C., Bjorquist A., Ungell A.L. Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: Comparison between human segments and Caco-2 cells. European Journal of Pharmaceutical Sciences 2006, 28:291-299.
40. Tandon R.K., Singh D.S., Arora R.R., Lal P., Tandon B.N. Epidemic dropsy in new delhi. The American Journal of Clinical Nutrition 1975, 28:883-887.
41. Unno T., Kwon S.C., Okamoto H., Irie Y., Kato Y., Matsuyama H., Komori S. Receptor signaling mechanisms underlying muscarinic agonist-evoked contraction in guinea-pig ileal longitudinal smooth muscle. British Journal of Pharmacology 2003, 139:337-350.
42. 3-receptor subtypes in muscarinic electrical and mechanical responses of intestinal smooth muscles. Neurophysiology 2003, 35:262-273.
43. Vavreckova C., Gawlik I., Muller K. Benzophenanthridine alkaloids of chelidonium majus; ii. Potent inhibitory action against the growth of human keratinocytes. Planta Medica 1996, 62:491-494.
44. Walsh M.P., Andrea J.E., Allen B.G., Clement-Chomienne O., Collins E.M., Morgan K.G. Smooth muscle protein kinase C. Canadian Journal of Physiology and Pharmacology 1994, 72:1392-1399.
45. 2+-independent contractions of vascular smooth muscle. Biochemistry and Cell Biology 1996, 74:485-502.
46. Wang C., Li J.F., Zhao L., Liu J., Wan J., Wang Y.X., Wang J. Inhibition of soc/ca2+/nfat pathway is involved in the anti-proliferative effect of sildenafil on pulmonary artery smooth muscle cells. Respiratory Research 2009, 10:123.
47. Wang H., Wang Y.S., Liu Z.Y., Sun Z.L. Inhibition effect of sanguinarine on contraction of rat intestinal smooth muscle cells. Journal of Hunan Agricultural University 2012, 5:519-525.
48. Yin G.H., Sun Z.N., Zhang L., Liu N., Song Y.Z., Zhu C.X., Wen F.J. Production of double-stranded RNA for interference with TMV infection utilizing prokaryotic bacterial expression system. Applied Microbiology and Biotechnology 2009, 84:323-333.
49. 3 subtypes. Molecular pharmacology 1991, 40:943-951.